Loading chat...
NY A05029
Bill
Status
2/11/2025
Primary Sponsor
Jonathan Jacobson
Click for details
AI Summary
-
Allows pharmacists to substitute brand name epinephrine auto-injectors (like EpiPen) with alternate versions containing the same active ingredients, dosage, and strength, even if the alternate is not on the official interchangeable drug products list
-
Substitution is only permitted when the alternate device would cost less for the purchaser
-
Pharmacists must obtain the patient's consent before dispensing the alternate auto-injector
-
Pharmacists are required to counsel patients on proper usage and operating features of the alternate epinephrine auto-injector, since different devices may have different administration methods
-
Substitution is prohibited if the prescriber specifically indicates the prescription must be dispensed as written
Legislative Description
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Last Action
referred to higher education
1/7/2026